Navigation Links
Genomic Health Announces Results From the Largest Genomic Analysis of Localized Clear Cell Renal Carcinoma at American Society of Clinical Oncology (ASCO) Annual Meeting
Date:6/4/2010

laboration with Pfizer Oncology for assessing prognosis in patients with stage 1-3 renal carcinoma, clear cell type, that has not spread to other parts of the body.

Researchers evaluated more than 700 candidate genes from 942 stage 1-3 clear cell renal carcinoma patients treated at Cleveland Clinic between 1985 and 2003.  Genomic factors strongly associated with risk of recurrence and clinical/pathologic covariates were identified.  The magnitude of hazard ratios was comparable to those of other clinically used prognostic markers, such as estrogen-receptor status and HER2 status in breast cancer.  Researchers suggest that these results could be used to create a multi-gene algorithm to predict recurrence of early-stage renal cell carcinoma.

"Genomic Health's collaboration with Pfizer represents an industry-leading example of academic, diagnostic and therapeutic organizations combining resources and areas of expertise in order to advance the field of personalized medicine," said Steven Shak, M.D., chief medical officer, Genomic Health.  "Similar to what Genomic Health found using its quantitative RT-PCR technology in breast and colon cancers, this study shows that renal carcinoma tumors are not all the same and we believe this finding has the potential to provide critical insight for determining how early-stage renal cell carcinoma is treated in the future."  

The clear cell type of renal carcinoma is the most common type of kidney cancer in adults, affecting an estimated 25,000 people each year in the United States, and the incidence of the disease may be increasing.  As part of the collaboration, Genomic Health and Pfizer applied the same molecular technology and clinical strategy Genomic Health used to develop its Oncotype DX® breast and colon cancer tests.


'/>"/>
SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Transgenomic to Present at the Noble Financial Sixth Annual Equity Conference - ONTRACK 2010
2. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
3. Genomic Health to Announce First Quarter 2010 Financial Results and Host Conference Call on Wednesday, May 5, 2010
4. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
5. Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
6. Transgenomic Reports Fourth Quarter Financial Results
7. AutoGenomics Announces the Launch of a Novel Test for B-RAF Mutations
8. NeoGenomics Schedules Its Q4 and Full Year 2009 Earnings Release for February 25, 2010
9. AutoGenomics Receives ISO Certification
10. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
11. Genomic Health Announces Year-End 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014 Research and Markets ... Type of Material, by Technology, by Application & by Region- ... offering. The demand for membranes is estimated ... the market to $29.31 billion Membrane technology was ... such as water filtration and kidney dialysis. In modern times, ...
(Date:8/19/2014)... , Aug. 19, 2014 Avizia, Inc., ... that it has closed an equity financing round led ... Middleland Capital. The new funding will be used to ... this financing round, Avizia welcomes Edward Kennedy , ... of directors. He joins Leonard Kurtzman , CFO ...
(Date:8/19/2014)... Calif. , Aug. 19, 2014  Cardiva Medical, ... two tranches of a $16.5 million Series 3 private ... with GE Capital. The Company will use the proceeds ... facility to expand commercial efforts for its VASCADE® Vascular ... . Investing in Series 3 private ...
Breaking Medicine Technology:Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Avizia Closes Funding Round 2Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2
... Inhibitex, Inc. (Nasdaq: INHX ) today announced that ... its common stock, at a purchase price of $4.10 per ... proceeds to Inhibitex from the sale of the shares, after ... to be approximately $44 million.  Inhibitex has granted the underwriters ...
... April 7, 2011 Vystar® Corporation ... Rubber Latex (NRL), a patented, all-natural raw latex ... non-rubbers found in natural rubber latex, has appointed ... (Logo: http://photos.prnewswire.com/prnh/20100203/CL48049LOGO) Ms. Kearney is ...
Cached Medicine Technology:Inhibitex Prices $47 Million Public Offering 2Inhibitex Prices $47 Million Public Offering 3Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 2Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing 3
(Date:8/20/2014)... Mass., (PRWEB) August 20, 2014 ... new report, PHOTONIC SENSORS AND DETECTORS: TECHNOLOGIES ... and detectors market is expected to grow to ... annual growth rate (CAGR) of 15.9%. Increasing ... region. , With a rapidly expanding range of ...
(Date:8/20/2014)... The Institute for Integrative Nutrition ... to announce its new partnership with California ... university offering graduate programs featuring flexible learning. Graduates ... now eligible to receive six graduate credits towards ... , “I’m so thrilled to announce this new ...
(Date:8/20/2014)... One Call Alert expands its line of personal emergency response ... device that connects customers to the help they need with ... 365 days a year. , ResCube can go anywhere—whether inside ... the T-Mobile nationwide network like a cell phone, so it ... with the other One Call Alert systems, ResCube wearers create ...
(Date:8/20/2014)... 19, 2014 (HealthDay News) -- Taking the ... of dying from heart-related causes, a new study suggests. ... year, the findings require urgent confirmation, said the Danish ... actual risk is small and that guidelines for the ... more information is available. One heart expert wasn,t ...
(Date:8/20/2014)... Plymouth University to be an official charity partner. Brain ... awareness of, and funding for, scientific research into brain ... A range of events and activities organised by the ... of staff and students, as well as other University ... The involvement of the wider community across the South ...
Breaking Medicine News(10 mins):Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 2Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 3Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 3Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 3Health News:Antibiotic Might Raise Heart Risks for Some 2Health News:Plymouth University chooses Brain Tumour Research as official charity 2
... Tenn., Dec. 16 Healthcare Management Systems,Inc.(R) (HMS) announced ... supply a full system of integrated clinical and financial ... their new, integrated HMS,system reinforces their commitment to providing ... Kimball Health Services has some healthcare ...
... reports that at its Annual General Meeting held today, shareholders overwhelmingly approved all of ... , , All seven Board members were re-elected ... , , , Donald H. Segal ... Officer, Kenneth A. Cawkell Director and Corporate ...
... this season of giving and sharing, St.,David,s Community Health ... million in grants to area nonprofit organizations that provide,access ... "Especially this year, we are ... for Central Texans," said Earl Maxwell, CEO of St. ...
... the largest privately held spinal implant manufacturer in the ... as Chief Financial Officer. Ms. DiCicco brings extensive experience ... manufacturer to the executive team at Globus. For the ... Nash Corporation (Nasdaq: KNSY ), a leading ...
... Inc.,(NYSE: STI ) announced today a ... take control of their healthcare costs. The,SunTrust Health ... a healthcare payment card, integrated account,management, online healthcare ... trusted custodial partner. , ...
... 2009 issue, The Journal of Nuclear Medicine SNM,s ... "This change to the publication allows the generous ... and organization of research reports," said Heinrich R. Schelbert, ... Nuclear Medicine . "Most important and critical, it strengthens ...
Cached Medicine News:Health News:Kimball Health Services Selects HMS to Provide Information Technology Infrastructure 2Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 2Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 3Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 4Health News:Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update 5Health News:$5.15 Million Provided to Support Local Health Care Needs 2Health News:$5.15 Million Provided to Support Local Health Care Needs 3Health News:$5.15 Million Provided to Support Local Health Care Needs 4Health News:Globus Medical Strengthens Executive Team with Appointment of CFO 2Health News:SunTrust Introduces Health Savings Accounts for Employers Seeking to Take Control of Healthcare Costs 2Health News:SunTrust Introduces Health Savings Accounts for Employers Seeking to Take Control of Healthcare Costs 3Health News:Journal of Nuclear Medicine premiers new, full-color design 2
... design and reduced dimensions provide ... control of IOL while grasping ... the optic. Curved shafts with ... curved. Smooth, flat, cross action ...
... implanting the haptic loop beneath the ... bag without wrist twisting. Angled 45 ... placed in the same vertical plane ... action handle with dull finish. Most ...
Smooth colibri tip used to grasp and subsequently retract the capsule during nucleus delivery. Serrated handle with polished finish....
Two rows of teeth on jaws provide a firm purchase on the nucleus fragment for removal. Flat handle with dull finish....
Medicine Products: